Lucid Diagnostics LUCD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$45.01M+27.2% | -$58.01M-27.4% | -$53.29M-18.9% | -$55.26M-18.4% | -$61.83M-31.5% | ||
| $873K-1.6% | $872K-25.3% | $885K-43.8% | $880K-55.6% | $887K-62.9% | ||
| —— | —— | $4.38M+15.7% | $4.43M+21.9% | $4.39M+19.0% | ||
| $631K+5,158% | $601K— | $512K+2,912% | $213K— | $12K— | ||
| —— | —— | —— | —— | -$140K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$684.25K— | ||
| -$46.12M-4.8% | -$46.49M-5.3% | -$43.78M+1.1% | -$43.06M-0.5% | -$43.99M-14.8% | ||
| —— | —— | —— | —— | $315K— | ||
| -$319K+54.6% | -$197K+69.5% | -$405K+27.9% | -$727K-222% | -$702K-191% | ||
| —— | —— | —— | —— | $16.57M— | ||
| —— | $0-100% | $904K— | $1.81M— | $2.71M— | ||
| $34K— | $17K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $49.08M+8.7% | $59.03M+22.3% | $77.03M+119% | $49.99M+41.1% | $45.16M+89.8% | ||
| —— | —— | $32.84M+444% | $6.2M— | $469K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$684.25K— | ||
| —— | —— | —— | —— | —— | ||
| —— | $0-100% | $904K— | $1.81M— | $2.71M— | ||
| —— | —— | —— | —— | $333.5K— | ||
| —— | —— | —— | —— | -$10.43M— | ||
| —— | -$1.08M— | -$808.5K— | -$539K— | -$269.5K— | ||
| —— | —— | —— | —— | -$45.89M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lucid Diagnostics generate?
- Lucid Diagnostics (LUCD) generated -$46.1M in operating cash flow over the trailing twelve months.
- What is Lucid Diagnostics's free cash flow?
- After $456.0K of capital expenditures, Lucid Diagnostics's free cash flow was -$47.1M over the trailing twelve months, down 40.1% year over year.
- Where does Lucid Diagnostics's cash flow data come from?
- Every line is extracted from Lucid Diagnostics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
